Boothbay Fund Management, LLC Aclaris Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $161,508 - $217,800	-20,470 Reduced 33.32%	40,973 $424,000
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $434,402 - $1.1 Million	61,443 New	61,443 $497,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $256,548 - $360,471	-19,174 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $30,863 - $53,487	-1,807 Reduced 8.61%	19,174 $337,000
Q1 2021 May 17, 2021	SELL	$5.86 - $27.73 $178,612 - $845,210	-30,480 Reduced 59.23%	20,981 $529,000
Q4 2020 Feb 12, 2021	BUY	$2.65 - $7.61 $136,371 - $391,618	51,461 New	51,461 $333,000
Q4 2019 Feb 14, 2020	SELL	$1.02 - $1.97 $11,934 - $23,049	-11,700 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.79 - $2.47 $9,243 - $28,899	11,700 New	11,700 $13,000
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $444,665 - $575,765	-20,711 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $476,767 - $596,476	20,711	20,711 $535,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.